P

Pierre Fabre

Allogeneic cell therapies development and commercialization

Late Phase Statistician - Clinical Development

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A Master's degree or PhD in Statistics or a related field is required.
  • A minimum of 6 years of experience in the pharmaceutical industry or a Contract Research Organization, with significant involvement in clinical trial development from the outset, is required.
  • Strong experience in the design, analysis, and reporting of phase IIb and/or phase III randomized controlled trials is required.
  • Strong experience in oncology clinical trials is required.
  • Advanced statistical analysis skills are required.
  • Proficiency in at least one of SAS or R is required.
  • Strong expertise in pivotal phase III development, registration activities, and regulatory strategy is required.
  • Strong knowledge of confirmatory clinical trial methodology, including estimands, multiplicity control, missing data methods, sensitivity analyses, interim analyses, and interpretation of efficacy and safety results, is required.
  • Experience supporting global regulatory submissions and health-authority interactions is required.
  • Experience with integrated summaries of efficacy and safety is required.
  • Experience supporting Independent Data Monitoring Committees or interim analyses is required.
  • Strong knowledge of international scientific and regulatory guidelines, including ICH, EMA, and FDA guidelines, is required.
  • Excellent written and verbal communication skills in English are required.

Responsibilities

  • Participate in the conception and design of phase IIb and phase III randomized controlled trials, providing statistical support for study design, sample size determination, randomization, endpoint selection, estimand definition, and confirmatory testing strategies.
  • Lead the statistical definition and justification of primary and key secondary endpoints, analysis populations, intercurrent event strategies, missing data approaches, sensitivity analyses, and multiplicity adjustments.
  • Contribute to the design and statistical oversight of interim analyses, Independent Data Monitoring Committees, adaptive confirmatory designs, and event-driven analyses, where applicable.
  • Act as the primary internal and external point of contact for statistical aspects of assigned projects and studies, attend project and study meetings, and provide statistical guidance.
  • Draft and/or validate synopses, protocols, case report forms, data review plans, statistical analysis plans, statistical results, study reports, and other study-level documents, ensuring timely delivery.
  • Program and/or validate statistical analyses using SAS and/or R.
  • Collaborate with clinicians to interpret results, develop key messages, and communicate findings to clinical and regulatory partners.
  • Contribute to submission strategies and statistical content for regulatory dossiers submitted to agencies such as EMA, FDA, and PMDA.
  • Coordinate the production of integrated summaries and pooled analyses of efficacy and safety, ensuring consistency across studies, endpoints, and populations.
  • Support regulatory inspections, submission-readiness activities, and traceability of statistical decisions and deliverables.
  • Work with clinicians and medical writers to prepare responses to questions from regulatory agencies, summaries of results for regulatory documents, and scientific articles.
  • Contribute to selecting and evaluating Contract Research Organizations, establishing clear requirements, and evaluating proposals.
  • Oversee review of statistical documents within the team and supervise operational activities outsourced to Contract Research Organizations, ensuring adherence to cost, timeline, and data-quality requirements.
  • Follow industry standards, including ensuring all statistics-related documentation is included in the electronic Trial Master File.

Desired Qualifications

  • Experience contributing to regulatory submissions, responses to regulatory authorities, or integrated efficacy and safety analyses is highly desirable.
  • Familiarity with adaptive confirmatory designs is optional.
  • Familiarity with CDISC standards and submission-ready clinical data packages is optional.
  • Experience with real-world evidence studies is optional.
  • Familiarity with biomarker data and its applications in randomized controlled trial designs is optional.

About the Company

Pierre Fabre

Allogeneic cell therapies development and commercialization

Pierre Fabre Pharmaceuticals (US) develops and commercializes allogeneic cell therapies for oncology and rare diseases. It focuses on bringing next-generation, donor-derived cell therapies to patients with high unmet medical needs and deepens partnerships with biotech companies to advance products through clinical manufacturing and distribution in the US.

Company size
5,001-10,000
Company stage
Seed
Total funding
$13.8M
Headquarters
Toulouse, France
Founded
1951

Recently Posted Jobs

Explore more opportunities at Pierre Fabre

See more jobs